Study overview
Ovarian cancer
Here you will find a list of all current studies in the field of ovarian cancer:
Initial therapy
NOGGO ov54 – SCOUT-1
NOGGO ov54 – Scout 1 Observational study to collect data from the everyday routine of patients with ovarian cancer undergoing initial therapy SCOUT-1 is a non-interventional study, a so-called observational...
read moreNIS CAROLIN
NIS Niraparib – NOGGO-ov45 – CAROLIN For patients with platinum-sensitive ovarian cancer who have no contraindications to niraparib This non-interventional observational study aims to investigate the long-term treatment with niraparib...
read moreAGO-OVAR 28 / ENGOT-OV57
AGO-OVAR 28 / ENGOT-ov57 A randomized open-label phase III study evaluating niraparib alone versus the combination of niraparib and bevacizumab in patients receiving chemotherapy for newly diagnosed advanced ovarian cancer...
read moreRecurrence therapy
NIS Niraparib – NOGGO-ov45 – CAROLIN
NIS Niraparib – NOGGO-ov45 – CAROLIN For patients with platinum-sensitive ovarian cancer who have no contraindications to niraparib This non-interventional observational study aims to investigate the long-term treatment with niraparib...
read moreENGOT-ov83 / CATALINA-2
ENGOT-ov83 / CATALINA-2 Therapeutic study to evaluate the efficacy and safety of the new compound TORL-1-23 in patients with advanced, platinum-resistant ovarian cancer CATALINA-2 is an international phase 2 trial...
read moreENGOT-ov47-TR/ NOGGO-TR2 – HELP-ER
ENGOT-ov47-TR/ NOGGO-TR2 – HELP-ER OBSERVATIONAL STUDY ON HE4 SERUM LEVELS IN THE BLOOD OF PATIENTS WITH FIRST RECURRENCE OF OVARIAN CANCER The HELP-ER study was designed to improve the treatment...
read moreAGO-OVAR 2.46 / ENGOT-ov81 / RAMP 301
AGO-OVAR 2.46 / ENGOT-ov81 / RAMP 301 CLINICAL STUDY ON RECURRENT LOW-GRADE SEROUS OVARIAN CANCER The AGO-OVAR 2.46 / ENGOT-ov81 / RAMP 301 is a randomized, open-label phase III trial...
read moreNOGGO S15 – FraStROC
NOGGO S15 – FraStROC Study for patients with recurrent or relapsed ovarian cancer. STUDY FOR PATIENTS WITH RECURRENT OR RELAPSED OVARIAN CANCER The FraStROC study is a non-interventional, prospective, multicenter...
read moreSurveys
Expression XVIII (18)
NOGGO S30/ Expression XVIII (18) INTERNATIONAL SURVEY ON THE IMPACT OF CRISES ON PATIENTS WITH GYNECOLOGICAL TUMORS Anxiety is a central issue in cancer patients with gynecologic diseases and can...
read moreEXPRESSION IX (9)
NOGGO S20 / ENGOTgyn4 – EXPRESSION IX (9) Long-term survival with gynecological cancer / Langzeitüberlebende mit gynäkologischen Krebserrankungen Based on the experience with Expression VI – Carolin meets HANNA, a...
read moreNOGGO S19 – EXPRESSION VIII (8)
NOGGO S19 – EXPRESSION VIII (8) For patients with a low-grade ovarian carcinoma (group A) or a borderline tumor of the ovary (group B – closed). Serous ovarian carcinoma is...
read moreEXPRESSION VI (6)
NOGGO S13 / ENGOT-ov40 – EXPRESSION VI (6)CAROLIN MEETS HANNA For patients with ovarian, fallopian tube and peritoneal cancer who were diagnosed at least 5 years ago NEW: Instead of...
read moreEXPRESSION XX (20)
NOGGO S33/ Expression XX (20) SURVEY AMONG PATIENTS WITH GYNECOLOGICAL TUMORS ON HOW TO DELIVER BAD NEWS Breaking bad news is an essential part of everyday medical practice, especially in...
read more
